HERMES MEDICAL SOLUTIONS AB

Hermes Medical Solutions is a Sweden-based molecular imaging software company founded in 1976, pioneering innovations in nuclear medicine and molecular imaging. The company's flagship product, Hermia, is a comprehensive vendor-neutral software platform designed for nuclear medicine and molecular imaging departments. Hermia enables healthcare professionals to visualize, process, analyze, report, and archive imaging data from PET, SPECT, CT, and MRI modalities. The platform streamlines clinical workflows, provides advanced quantitative reconstruction tools (including SUV SPECT), and supports personalized dosimetry for theranostic applications. Hermia serves approximately 30,000 users across 70 countries and is used by university hospitals and healthcare providers globally. The software suite supports all clinical molecular imaging specialties and integrates seamlessly with existing hospital IT systems and DICOM-compliant equipment, regardless of manufacturer. Hermes has achieved regulatory clearances including FDA approval and CE marking, with recent ARTG listing in Australia.